VeriMomSollte ich retinoyl oligopeptide-112 in der Schwangerschaft meiden? | VeriMom
No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
What to use instead
Pregnancy-safe ingredients that serve a similar function:
FAQ
- Ist retinoyl oligopeptide-112 in der Schwangerschaft sicher?
- No EU ban or harmonised CLP classification was found for Retinoyl Oligopeptide‑112, but the ingredient contains a retinoyl (vitamin‑A) moiety. EU/SCCS guidance treats some retinoids (e.g., retinoic acid) as prohibited and limits other vitamin A derivatives because of developmental/embryotoxic concern; by your scoring rules a structural/class-based concern (retinoid moiety) justifies h=1 and a theoretical mechanism justifies m=1. No specific reproductive/teratology animal or human data for this exact INCI were located. (Sources: cosmile ingredient entry; SCCS opinion on vitamin A; EU Annex II/III context.).
- Ist retinoyl oligopeptide-112 während des Stillens sicher?
- No specific data on milk excretion for this ingredient were located. Topical retinoids are generally advised against in pregnancy and often avoided during breastfeeding as a precaution; because the compound contains a retinoyl group there is a class‑based/theoretical concern (h=1, m=1). Measured systemic absorption for retinoid‑peptide conjugates was not found, so exposure scored as low but measurable (e=1).
- Ist retinoyl oligopeptide-112 sicher für Babyhaut?
- Infant skin has higher permeability; per your rules increase exposure by +1 when adult exposure is measurable. No infant‑specific safety data were found for Retinoyl Oligopeptide‑112; therefore h and m remain the same as adults (structural/class concern), and e is increased to 2 for 0–3‑year‑old skin. Keep infants’ direct contact with treated skin minimal (no application to chest/areas the baby may contact) in the absence of data.
- Wie bewertet VeriMom retinoyl oligopeptide-112?
- VeriMom bewertet retinoyl oligopeptide-112 mit 13/100 (hohes Risiko) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu retinoyl oligopeptide-112?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu retinoyl oligopeptide-112 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.